P476 Efficacy and safety of 2 vedolizumab IV regimens in patients with perianal fistulising Crohn’s disease: results of the ENTERPRISE study
ECCO'20 Vienna
2020
P477 Italian real-life study evaluating the long-term effectiveness of vedolizumab for the treatment of inflammatory bowel disease: the elderly cohort
ECCO'20 Vienna
2020
P478 Thiopurines’ metabolites levels and drug toxicity: a systematic review and meta-analysis
ECCO'20 Vienna
2020
P479 The effect of adalimumab on linear growth in children with Crohn’s disease: a post hoc analysis of the PAILOT randomised control trial
ECCO'20 Vienna
2020
P480 Efficiency and safety of endoscopic balloon dilatation of ileocolonic anastomotic strictures in patients with Crohn’s disease: A multicentric retrospective study
ECCO'20 Vienna
2020
P482 Patient and physician perspectives on the management of inflammatory bowel disease: Disease remission and durability of treatment
ECCO'20 Vienna
2020
P483 Vedolizumab serum drug levels are not associated with clinical outcomes or markers of disease activity in inflammatory bowel disease
ECCO'20 Vienna
2020
P484 Effectiveness and safety of ustekinumab in patients with Crohn’s disease: a real-world experience
ECCO'20 Vienna
2020
P485 Switching infliximab biosimilar: No adverse impact on inflammatory bowel disease control or drug levels with the first or second switch
ECCO'20 Vienna
2020
P487 Development and validation of a new patient-reported outcome measure for Crohn’s perianal fistula: Crohn’s anal fistula quality-of-life (CAF-QoL) scale
ECCO'20 Vienna
2020
P488 How reliable is the online medical information on paediatric inflammatory bowel diseases?
ECCO'20 Vienna
2020
P489 Are patients with inflammatory bowel disease receiving an adequate immunisation?
ECCO'20 Vienna
2020
P490 Assessment of body weight changes in patients with inflammatory bowel diseases initiating biologic therapy: A prospective cohort study
ECCO'20 Vienna
2020
P491 De-escalation of dose-intensified anti-TNF therapy in IBD patients in sustained deep remission
ECCO'20 Vienna
2020
P492 Use of bowel ultrasound to assess disease activity in Crohn’s disease patients after induction therapy with infliximab
ECCO'20 Vienna
2020
P493 Segmental colectomy vs. extended colectomy for colonic Crohn’s disease: results from 112 consecutive patients
ECCO'20 Vienna
2020